ABAlfa H.C. Bai

Alfa H.C. Bai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alfa H.C. Bai has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • André Oberthuer

    Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Cologne 50924, Germany

    1 shared publication
  • Barbara Banelli

    Laboratory of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Genova, Italy

    1 shared publication
  • Claudio Brigati

    Laboratory of Tumor Genetics and Epigenetics, IRCCS A.O.U. San Martino–IST National Cancer Research Institute, Genoa 16132, Italy

    1 shared publication
  • Francesca Valdora

    Department of Experimental Medicine (DIMES), University of Genoa-IRCCS A.O.U. San Martino–IST National Cancer Research Institute, Genoa 16132, Italy

    1 shared publication
  • Gian Paolo Tonini

    Laboratory of Neuroblastoma, Onco/Hematology Laboratory Department SDB University of Padua, Pediatric Research Institute, Padua 35127, Italy

    1 shared publication
  • Giuseppe Cinalli

    Pediatric Neurosurgery, Santobono-Pausilipon Children's Hospital, Naples 80122, Italy

    1 shared publication

Latest Publications

  • Open Access

    Epigenetic Silencing of DKK3 in Medulloblastoma

    by Francesca Valdora, Barbara Banelli, Sara Stigliani, Stefan M. Pfister, Stefano Moretti, Marcel Kool, Marc Remke, Alfa H.C. Bai, Claudio Brigati, Thomas Hielscher, et al.

    Medulloblastoma (MB) is a malignant pediatric brain tumor arising in the cerebellum consisting of four distinct subgroups: WNT, SHH, Group 3 and Group 4, which exhibit different molecular phenotypes. We studied the expression of Dickkopf (DKK) 1–4 family genes, inhibitors of the Wnt signaling cascade, in MB by screening 355 expression profiles derived from four independent datasets. Upregulation of DKK1, DKK2 and DKK4 mRNA was observed in the WNT subgroup, whereas DKK3 was downregulated in 80% MBs across subgroups with respect to the normal cerebellum (p < 0.001). Since copy number aberrations targeting the DKK3 locus (11p15.3) are rare events, we hypothesized that epigenetic factors could play a role in DKK3 regulation. Accordingly, we studied 77 miRNAs predicting to repress DKK3; however, no significant inverse correlation between miRNA/mRNA expression was observed. Moreover, the low methylation levels in the DKK3 promoters (median: 3%, 5% and 5% for promoter 1, 2 and 3, respectively) excluded the downregulation of gene expression by methylation. On the other hand, the treatment of MB cells with Trichostatin A (TSA), a potent inhibitor of histone deacetylases (HDAC), was able to restore both DKK3 mRNA and protein. In conclusion, DKK3 downregulation across all MB subgroups may be due to epigenetic mechanisms, in particular, through chromatin condensation.